AcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results

REDWOOD CITY, Calif., Aug. 5, 2019 /PRNewswire/ --AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its second quarter 2019 financial results.